Fujirebio moves into GoCo Health Innovation City
“Fujirebio shares GoCo Health Innovation City's vision about collaboration as the key to innovation. We are thrilled that they chose to establish themselves here early, and we notice that their investment results in other companies following their lead,” said Joakim Garfvé, Property Manager at Next Step Group, one of the initiators of GoCo Health Innovation City, in a press release.
“Innovative solutions for better health care and health require a thorough understanding of medical needs and a close collaboration between healthcare providers, academic researchers, the pharmaceutical industry, and the diagnostic industry. That is the kind of platform that GoCo Health Innovation offers,” said Christina Hall, Managing Director at Fujirebio Diagnostics AB.
Fujirebio’s new facility is one of the first new buildings to be completed at GoCo Health Innovation City, which also includes AstraZeneca’s R&D centre.
Earlier this month Fujirebio’s building was officially inaugurated, a little over one and a half years after the contract was signed at the Swedish embassy in Tokyo.
“We are delighted with the building and that Next Step Group and BRA Bygg have been able to meet our specific requirements and deliver such an advanced solution in such a short time. We look forward to collaborating with more companies that establish themselves here,” said Christina Hall.
GoCo’s northern neighbourhood houses AstraZeneca, with over 2000 staff, as well as its BioVentureHub, a novel life science incubator with over 30 biotech companies and academic groups.
The southern neighbourhood is under development and when completed it will feature 100,000 sqm of space and capacity for 350 companies and 7,000 people.
- Gothenburg's life science industry
- June Medical to establish EU-base in Gothenburg
- 'Gothenburg has taken over as Sweden’s R&D region for businesses'
- BioVentureHub – new collaboration can strengthen digital health expertise
- New health innovation initiative unveiled
We are here to help
Want to learn more about the life science industry in Gothenburg and how we can help you establish or invest in the region? Please contact our life science investment advisor, Iris Öhrn: +46313676130 or firstname.lastname@example.org